Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02513550

Public ClinicalTrials.gov record NCT02513550. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients With Moderate-to-Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy of ixekizumab dosing regimens in participants with plaque psoriasis.

Study identification

NCT ID
NCT02513550
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,257 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2015 (Type not available)
Primary completion
Nov 2016 (Actual)
Completion
Aug 3, 2017 (Actual)
Last update posted
Jun 17, 2020

2015 – 2017

United States locations

U.S. sites
59
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center PC Birmingham Alabama 35205 —
Anaheim Clinical Trials, LLC Anaheim California 92801 —
David Stoll, M.D. Beverly Hills California 90212 —
Dermatology Research Associates Los Angeles California 90045 —
Center for Dermatology and Laser Surgery Sacramento California 95819 —
Medical Center for Clinical Research San Diego California 92108 —
University Clinical Trials, Inc. San Diego California 92123 —
Clinical Science Institute Santa Monica California 90404 —
Cherry Creek Research, Inc Denver Colorado 80209 —
Florida Academic Dermatology Centers Coral Gables Florida 33134 —
Avail Clinical Research LLC DeLand Florida 32720 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Renstar Medical Research Ocala Florida 34471 —
Ameriderm Research Ormond Beach Florida 32174 —
University of South Florida Tampa Florida 33624 —
Advanced Medical Research Atlanta Georgia 30342 —
University Dermatology Darien Illinois 60561 —
Deaconess Clinic Inc Evansville Indiana 47714 —
Dawes Fretzin Clinical Research Indianapolis Indiana 46256 —
The South Bend Clinic South Bend Indiana 46617 —
Kansas City Dermatology, PA Overland Park Kansas 66215 —
Heartland Research Associates Wichita Kansas 67207 —
Dermatology Specialist Louisville Kentucky 40202 —
Dr. Shondra Smith MD Lake Charles Louisiana 70605 —
DermAssociates, P.C. Rockville Maryland 20850 —
ActivMed Practices & Research, Inc Beverly Massachusetts 01915 —
Central Dermatology PC St Louis Missouri 63117 —
ActivMed Practices & Research, Inc Newington New Hampshire 03801 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
Academic Dermatology Associates Albuquerque New Mexico 87106-5239 —
Mount Sinai School of Medicine Dermatology Clinical Trials New York New York 10029 —
Skin Search of Rochester, Inc Rochester New York 14623 —
University of North Carolina Dermatology and Skin Cancer Center Chapel Hill North Carolina 27516 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Wilmington Dermatology Center Wilmington North Carolina 28405 —
Piedmont Medical Research Winston-Salem North Carolina 27103 —
University Hospitals of Cleveland Cleveland Ohio 44106-5055 —
Healthcare Research Consultant Tulsa Oklahoma 74135 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Oregon Medical Research Center Portland Oregon 97223 —
Dermatology and Skin Surgery Center Exton Pennsylvania 19341 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Pennsylvania Regional Center for Arthritis & Osteoarthritis Wyomissing Pennsylvania 19610 —
Yardley Dermatology Yardley Pennsylvania 19067 —
Clinical Partners LLC Johnston Rhode Island 02919 —
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464 —
The Skin Wellness Center PC Knoxville Tennessee 37922 —
Austin Dermatology Associates Austin Texas 78705 —
Menter Dermatology Research Institute Dallas Texas 75246 —
Center for Clinical Studies Houston Texas 77004 —
Center for Clinical Studies Houston Texas 77065 —
Pflugerville Dermatology Clinical Research Center Pflugerville Texas 78660 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Center for Clinical Studies Webster Texas 77598 —
University of Utah Medical Center Salt Lake City Utah 84132 —
Virginia Clinical Research Norfolk Virginia 23507 —
Dermatology Associates Seattle Washington 98101 —
Multicare Health System Tacoma Washington 98405 —
Wenatchee Valley Hospital & Clinics Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02513550, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02513550 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →